| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1999;34:1032-1040.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Division of Cardiology and Hypertension Center, Department of Medicine, New York Presbyterian Hospital, Joan and Sanford I. Well Medical College of Cornell University, New York, NY.
Correspondence to Richard B. Devereux, MD, Division of Cardiology, Box 222, New York Presbyterian HospitalWeill Medical College of Cornell University, 525 E 68th St, New York, NY 10021. E-mail rbdevere{at}mail.med.cornell.edu
AbstractAppropriateness of left ventricular (LV) mass to cardiac workload can be evaluated by the ratio of observed LV mass to the value predicted for an individuals gender, height2.7, and stroke work at rest (%PLVM). It is unclear which pathophysiological factors are associated with inappropriately high LV mass in hypertensive subjects. Adequate LV mass was defined by the 90% confidence interval (73% to 128%) of the distribution of %PLVM in 393 normal-weight normotensive subjects. In 185 hypertensive subjects (aged 56±11 years; 60% male, 29% black), according to %PLVM, 164 (88%) had adequate LV mass, 16 (9%) had inappropriately high LV mass (%PLVM >128%), and 5 (3%) had %PLVM <73% (low LV mass). Age, gender, smoking habit, proportion of never-treated subjects, total cholesterol, triglycerides, and creatinine levels did not differ significantly between subjects with adequate and inappropriately high LV mass. Body mass index, fasting glucose, and proportion of black subjects were higher (all P<0.05), while HDL cholesterol was lower (P<0.05) in subjects with inappropriately high LV mass. Blood pressure at the echocardiogram was comparable between subjects with adequate and inappropriately high LV mass, but the latter group had higher ambulatory blood pressure (P<0.01). Subjects with inappropriately high LV mass also had higher aortic root dimension and LV relative wall thickness and relatively lower LV systolic performance than those with adequate LV mass (all P<0.001). Larger aortic root diameter and lower systolic function were also found in hypertensive subjects with inappropriate LV hypertrophy compared with those with adequate LV hypertrophy. In an exploratory case-control study that compared subjects with low %PLVM with age-matched counterparts with adequate LV mass, low %PLVM was associated with lower body mass index, more favorable metabolic profile, and higher LV myocardial contractility. Higher body mass index, larger aortic root, and black race were independent correlates of increased %PLVM. Thus, in arterial hypertension, levels of LV mass inappropriately high for gender, cardiac workload, and height2.7 are associated with higher body mass index, higher ambulatory blood pressure, larger aortic root diameters, and relatively low myocardial contractility.
Key Words: hypertrophy, left ventricular hypertension, white coat obesity metabolism echocardiography
This article has been cited by other articles:
![]() |
E. R. Porrello, J. R. Bell, J. D. Schertzer, C. L. Curl, J. R. McMullen, K. M. Mellor, R. H. Ritchie, G. S. Lynch, S. B. Harrap, W. G. Thomas, et al. Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R672 - R680. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Muiesan, M. Salvetti, A. Paini, C. Agabiti-Rosei, C. Monteduro, G. Galbassini, E. Belotti, C. Aggiusti, D. Rizzoni, M. Castellano, et al. Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism Hypertension, September 1, 2008; 52(3): 529 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lopez, J. M. Castellano, A. Gonzalez, J. Barba, and J. Diez Association of Increased Plasma Cardiotrophin-1 With Inappropriate Left Ventricular Mass in Essential Hypertension Hypertension, November 1, 2007; 50(5): 977 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Muiesan, M. Salvetti, A. Paini, C. Monteduro, G. Galbassini, B. Bonzi, P. Poisa, E. Belotti, C. Agabiti Rosei, D. Rizzoni, et al. Inappropriate Left Ventricular Mass Changes During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients Hypertension, May 1, 2007; 49(5): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF] |
||||
![]() |
M. C. C. Borges, R. C.R. Colombo, J. G. F. Goncalves, J. d. O. Ferreira, and K. G. Franchini Longitudinal Mitral Annulus Velocities Are Reduced in Hypertensive Subjects With or Without Left Ventricle Hypertrophy Hypertension, May 1, 2006; 47(5): 854 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Berenji, M. H. Drazner, B. A. Rothermel, and J. A. Hill Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H8 - H16. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-K. Siegel, M. Planert, S. Rademacher, A. P. Mehr, P. Kossmehl, M. Wehland, M. Stoll, and R. Kreutz Genetic Loci Contribute to the Progression of Vascular and Cardiac Hypertrophy in Salt-Sensitive Spontaneous Hypertension Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1211 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Romano, M. Chinali, F. Pasanisi, R. Greco, A. Celentano, A. Rocco, V. Palmieri, A. Signorini, F. Contaldo, and G. de Simone Reduced hemodynamic load and cardiac hypotrophy in patients with anorexia nervosa Am. J. Clinical Nutrition, February 1, 2003; 77(2): 308 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kozakova, G. de Simone, C. Morizzo, and C. Palombo Coronary Vasodilator Capacity and Hypertension-Induced Increase in Left Ventricular Mass Hypertension, February 1, 2003; 41(2): 224 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. de Simone, P. Verdecchia, S. Pede, M. Gorini, and A. P. Maggioni Prognosis of Inappropriate Left Ventricular Mass in Hypertension: The MAVI Study Hypertension, October 1, 2002; 40(4): 470 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Harrap, V. R. Danes, J. A. Ellis, C. D. Griffiths, E. F. Jones, and L. M. D. Delbridge The hypertrophic heart rat: a new normotensive model of genetic cardiac and cardiomyocyte hypertrophy Physiol Genomics, April 10, 2002; 9(1): 43 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. de Simone, F. Pasanisi, and F. Contaldo Link of Nonhemodynamic Factors to Hemodynamic Determinants of Left Ventricular Hypertrophy Hypertension, July 1, 2001; 38(1): 13 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Harrap, V. R. Danes, J. A. Ellis, C. D. Griffiths, E. F. Jones, and L. M. D. Delbridge The hypertrophic heart rat: a new normotensive model of genetic cardiac and cardiomyocyte hypertrophy Physiol Genomics, April 10, 2002; 9(1): 43 - 48. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |